TARA-002 shows strong early results in trial for paediatric lymphatic malformations

Protara’s phase 2 STARBORN-1 study reports high response rates and no serious adverse events

Libtayo approved in EU as first adjuvant immunotherapy for high-risk CSCC

New authorisation marks major milestone in earlier treatment of skin cancer

Inflammation turns bone marrow into a breeding ground for disease

Researchers discovered that chronic inflammation fundamentally remodels the bone marrow, allowing mutated stem cell clones to quietly gain […]

Frances Helen Booth

bmj;391/nov19_1/r2398/FAF1faFrances was born in Leeds into a family of four siblings and wanted to become a doctor from […]

CETIRIZINE HYDROCHLORIDE (cetirizine hydrochloride allergy) tablet [LEADER/ CARDINAL HEALTH 110, INC.]

Updated Date: Mon, 17 Nov 2025 00:00:00 EST

DYNAMO DELAY (lidocaine) spray [Momentum Management LLC]

Updated Date: Mon, 17 Nov 2025 00:00:00 EST

PURELL HAND SANITIZER SP BERRY AND CITRUS (alcohol) spray [GOJO Industries, Inc.]

Updated Date: Mon, 17 Nov 2025 00:00:00 EST

PILOCARPINE HYDROCHLORIDE tablet, film coated [Aurobindo Pharma Limited]

Updated Date: Mon, 17 Nov 2025 00:00:00 EST

ESOMEPRAZOLE MAGNESIUM capsule, delayed release [LEADER/ CARDINAL HEALTH 110, INC.]

Updated Date: Mon, 17 Nov 2025 00:00:00 EST

Cellbyte raises $2.75m to slash drug launch timelines with AI

Munich-based start-up backed by Frontline Ventures and Y Combinator eyes global expansion